Analysis of biomarker data: Logs, odds ratios, and receiver operating characteristic curves

Current Opinion in HIV and AIDS

Volumn 5, Issue 6, 2010, Pages 473-479

  Grund, Birgit ^a   Sabin, Caroline ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Biomarker analysis; C statistic; odds ratio; receiver operating characteristic curve; risk prediction accuracy

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ACCURACY; BIOMARKER ANALYSIS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; DATA ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REVIEW; STANDARDIZATION; STATISTICS;

BIOLOGICAL MARKERS; DATA INTERPRETATION, STATISTICAL; HUMANS; LOGISTIC MODELS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 77958550314     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32833ed742     Document Type: Review

References (34)

1. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203.
2. Mocroft A, Wyatt C, Szczech L, et al. Interruption of antiretroviral therapy is associated with increased plasma cystatin C. AIDS 2009; 23:71-82.
3. Neuhaus J, Jacobs J, Baker J, et al. Markers of inflammation, coagulation and renal function are elevated in adults with HIV infection. J Infect Dis 2010; 201:1788-1795.
4. Rodger A, Fox Z, Lundgren JD, et al. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis 2009; 200:973-983.
5. Kay R, Little S. Transformations of the explanatory variables in the logistic regression model for binary data. Biometrika 1987; 74:495-501.
6. Cook RD, Weisberg S. Applied regression including computing and graphics. New York: Wiley; 1999. Chapter 22. pp. 549-579.
7. Melander O, Newton-Cheh C, Almgren P, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009; 302:49-57
8. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355:2631-2639.
9. Buckley DI, Fu R, Freeman M, et al. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive services task force. Ann Intern Med 2009; 151:483-495.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
11. Grundy SM, Cleeman JI, Merz CNB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004; 110:227-239.
12. Wilson P, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-1847.
13. Lloyd-Jones DM, Liu K, Tian L, et al. Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 2006; 145:35-42.
14. U. S. Preventive Services Task Force. Using nontraditional risk factors in coronary heart disease risk assessment: U.S. preventive services task force recommendation statement. Ann Intern Med 2009; 151:474-482.
15. Folsom AR, Chambless LE, Ballantyne CM, et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med 2006; 166:1368-1373.
16. CookNR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115:928-935.
17. Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006; 145:21-29.
18. Gu W, Pepe MS. Measures to summarize and compare the predictive capacity of markers. Int J Biostat 2009:article 27.
19. Pepe MS, Feng Z, Huang Y, et al. Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol 2008; 167:362-368.
20. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
21. Pepe MS, Janes H, Longton G, et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004; 159:882-890.
22. Ridker PM, Buring JE, Rifai N, et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds risk score [erratum appears in JAMA 2007; 297:1433]. JAMA 2007; 297:611-619.
23. Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York, NY: Springer; 2001.
24. Gonen M. Analyzing receiver operating characteristic curves with SAS. Cary, NC: SAS Press; 2007.
25. Pepe MS. The statistical evaluation of medical tests for classification and prediction. Oxford, UK: Oxford University Press; 2003.
26. Greenland S. The need for reorientation toward cost-effective prediction: comments on 'Evaluating the added predictive ability of a new marker: from ROC curve to reclassification and beyond', by MJ. Pencina et al., Stat Med. Stat Med 2008; 27:199-206.
27. Cook NR. Comments on 'Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond', by M.J. Pencina et al., Stat Med Stat Med 2008; 27:191-195. doi: 10.1002/sim.2929. (Pubitemid 351193639)
28. Janes H, Pepe MS,Gu W. Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med 2008; 149:751-760.
29. de Ruijter W, Westendorp RGJ, Assendelft WJJ, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 2009; 338: a3083.
30. Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med 2006; 355:2615-2617.
31. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172; discussion
32. McGeechan K, Macaskill P, Irwig L, et al. Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. Arch Intern Med 2008; 168:2304-2310.
33. Hosmer DW, Hosmer T, Le Cessie S, et al. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997; 1997:965-980.
34. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2010.